4//SEC Filing
BIOVERIS CORP 4
Accession 0001209191-07-039315
CIK 0001264899operating
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 5:17 PM ET
Size
14.3 KB
Accession
0001209191-07-039315
Insider Transaction Report
Form 4
BIOVERIS CORPBIOV
WOHLSTADTER SAMUEL J
DirectorChief Executive Officer10% Owner
Transactions
- Disposition to Issuer
Restricted Stock
2007-06-26$21.50/sh−237,559$5,107,519→ 0 total - Disposition to Issuer
Common Stock
2007-06-26$21.50/sh−5,027,878$108,099,377→ 0 total - Disposition to Issuer
Series B Preffered Stock
2007-06-26−1,000→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2007-06-26−50,000→ 0 total(indirect: By Spouse)Exercise: $7.84From: 2007-06-26→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2007-06-26−282,000→ 0 totalExercise: $7.84From: 2007-06-26→ Common Stock (282,000 underlying)
Footnotes (6)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger ("merger agreement"), dated as of April 4, 2007, among the Issuer, Roche Holding Ltd and Lili Acquisition Corporation, in exchange for the right to receive $21.50 in cash, without interest, per share of Common Stock of the Issuer held by the reporting person.
- [F2]Disposed of pursuant to the Transaction Agreement, by and between Samuel J. Wohlstadter and Roche Holding Ltd, dated as of April 4, 2007, in exchange for $2,750,000 in cash.
- [F3]These restricted stock awards were cancelled pursuant to the merger agreement in exchange for the right to receive a cash payment equal to the product of the number of shares of Common Stock subject to the restricted stock award multiplied by $21.50.
- [F4]The amount set forth in the "Conversion or Exercise Price of Derivative Security" column is calculated based upon the average exercise price per share of the options outstanding held by the reporting person.
- [F5]These options were cancelled pursuant to the merger agreement in exchange for the right to receive a cash payment equal to the product of the number of shares subject to such option multiplied by the excess, if any, of (a) $21.50 per share over (b) the exercise price of such option.
- [F6]All options expire after June 26, 2007.
Documents
Issuer
BIOVERIS CORP
CIK 0001264899
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001264899
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 5:17 PM ET
- Size
- 14.3 KB